Early research (Phase 1)Study completedNCT03269071What this trial is testingNeural Stem Cell Transplantation in Multiple Sclerosis PatientsWho this might be right forProgressive Multiple Sclerosis IRCCS San Raffaele 4
Testing effectiveness (Phase 2)Study completedNCT03423121What this trial is testingA Trial of Bile Acid Supplementation in Patients With Multiple SclerosisWho this might be right forProgressive Multiple Sclerosis Johns Hopkins University 59
Testing effectiveness (Phase 2)Study completedNCT01450488What this trial is testingMasitinib in Primary Progressive Multiple Sclerosis or Relapse-free Secondary Progressive Multiple SclerosisWho this might be right forMultiple Sclerosis AB Science 35
Early research (Phase 1)UnknownNCT02903537What this trial is testingTolerogenic Dendritic Cells as a Therapeutic Strategy for the Treatment of Multiple Sclerosis Patients (TOLERVIT-MS)Who this might be right forMultiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Chronic Progressive Fundació Institut Germans Trias i Pujol 16
Not applicableUnknownNCT06320444What this trial is testingNon-invasive Spinal, Cortical, and Sensorimotor Biomarkers in Motor Neurone DiseaseWho this might be right forMotor Neuron Disease, Amyotrophic Lateral SclerosisMotor Neuron Disease Progressive Spinal Muscle AtrophyPrimary Lateral Sclerosis+2 more University of Dublin, Trinity College 240
Not applicableStudy completedNCT04545372What this trial is testingAerobic Exercises for Multiple SclerosisWho this might be right forMultiple Sclerosis, Primary Progressive South Valley University 30
Not applicableStudy completedNCT04593927What this trial is testingLong Term Special Drug Use-results Surveillance for Mayzent in SPMS PatientsWho this might be right forSecondary Progressive Multiple Sclerosis (SPMS) Novartis Pharmaceuticals 451
Very early researchNot Yet RecruitingNCT07583030What this trial is testingA Clinical Study to Evaluate LVIVO-TaVec400 for the Treatment of Relapsed/Refractory Autoimmune DiseasesWho this might be right forRelapsed/Refractory Systemic Lupus Erythematosus (r/r SLE)Relapsed/Refractory IgG4-Related Disease (r/r IgG4-RD)Progressive Multiple Sclerosis (PMS)+1 more Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 44
Large-scale testing (Phase 3)Active Not RecruitingNCT05210621What this trial is testingLONG-TERM EFFECTIVENESS AND SAFETY EVALUATION OF OCRELIZUMABWho this might be right forMultiple Sclerosis Centre Hospitalier Universitaire de Nice 72
Testing effectiveness (Phase 2)Ended earlyNCT03283826What this trial is testingPhase 1/2 Study to Evaluate the Safety and Efficacy of ATA188 in Subjects With Progressive Multiple SclerosisWho this might be right forPrimary Progressive Multiple SclerosisSecondary Progressive Multiple Sclerosis Atara Biotherapeutics 134
Not applicableEnded earlyNCT04746976What this trial is testingStudy of Diroximel Fumarate in the Real-World SettingWho this might be right forRelapsing Forms of MS Biogen 75
Testing effectiveness (Phase 2)Looking for participantsNCT07282574What this trial is testingEvaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of RO7268489 as Add-on Therapy to Ocrelizumab, in Participants With Progressive Forms of Multiple Sclerosis (MS)Who this might be right forProgressive Multiple Sclerosis Hoffmann-La Roche 360
Not applicableUnknownNCT06485115What this trial is testingTelerehabilitation in Progressive Multiple SclerosisWho this might be right forProgressive Multiple Sclerosis Universita di Verona 78
Not applicableLooking for participantsNCT06203106What this trial is testingNYSCF Scientific Discovery BiobankWho this might be right forALSAmyotrophic Lateral SclerosisAlzheimer Disease+26 more New York Stem Cell Foundation Research Institute 10,000
Not applicableStudy completedNCT01235455What this trial is testingPortuguese Observational Survey to Assess Drug Adherence in Patients With Multiple Sclerosis After Conversion to Betaferon by Using Elements of the BetaPlus Program - Nurse Support, Auto-injectorsWho this might be right forRelapsing Remitting Multiple Sclerosis (RRMS)Secondary Progressive Multiple Sclerosis (SPMS) Bayer 10
Testing effectiveness (Phase 2)Study completedNCT00228163What this trial is testingLong Term Safety and Efficacy of Teriflunomide (HMR1726) in Multiple Sclerosis With RelapsesWho this might be right forMultiple Sclerosis Sanofi 147
Not applicableStudy completedNCT03302806What this trial is testingStudy to Assess Effect and Safety of High Dose of Biotin (Qizenday®) in Progressive Multiple SclerosisWho this might be right forProgressive Multiple Sclerosis Nantes University Hospital 103
Post-approval studies (Phase 4)Looking for participantsNCT07609719What this trial is testingOcrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 TherapyWho this might be right forMultiple Sclerosis Genentech, Inc. 100
Not applicableLooking for participantsNCT07392879What this trial is testingBringing the Outdoors In: Virtual Nature Walks for Depression in Multiple Sclerosis (MS) PatientsWho this might be right forProgressive Multiple SclerosisDepression University of Michigan 40
Testing effectiveness (Phase 2)Looking for participantsNCT03109288What this trial is testingTargeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)Who this might be right forMultiple Sclerosis National Institute of Allergy and Infectious Diseases (NIAID) 250